Drug Type Herbal medicine |
Synonyms- |
Target |
Action modulators |
Mechanism ATF4 modulators(activating transcription factor 4 modulators), PERK modulators(eukaryotic translation initiation factor 2 alpha kinase 3 modulators), eIF2α modulators(eukaryotic translation initiation factor 2A modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Nephrotoxicity | Preclinical | China | 29 Sep 2025 |





